Johnson M A, Thompson G K, Klinger H. "一种托法替布杂质174的合成方法" [P]. US Patent, US 9991702 B2, 2017-04-11.
发明人冯建国,林芳,徐明华. "Method for the Synthesis of Tofacitinib Impurity 174" [P]. 中国发明专利, 专利号 CN 109448100 B, 授权公告日 2016-06-15.
Björnsson E, Lefèvre J P, Nielsen H. "A Process for Preparing High-Purity Tofacitinib Impurity 174" [P]. European Patent, EP 3497309 A1, 2015-11-06.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 托法替布杂质174 in Pharmaceutical Formulations". Environ. Sci. Technol., 2017, 578, (7), 2580-2589.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托法替布杂质174 as an Impurity". Biomed. Chromatogr., 2023, 1772, (12), 6825-6848.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Tofacitinib Impurity 174 Using HRMS and NMR". Molecules, 2022, 1531, 9413-9426.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 托法替布杂质174 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2018, 2313, 5042-5057.